Provided by Tiger Trade Technology Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

45.92
-0.2800-0.61%
Post-market: 46.840.9196+2.00%19:50 EDT
Volume:1.30M
Turnover:59.45M
Market Cap:3.25B
PE:-19.25
High:46.54
Open:46.10
Low:44.77
Close:46.20
52wk High:94.90
52wk Low:13.22
Shares:70.84M
Float Shares:51.39M
Volume Ratio:1.46
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3852
EPS(LYR):-2.3276
ROE:-11.86%
ROA:-9.39%
PB:2.15
PE(LYR):-19.73

Loading ...

Structure Therapeutics Down 5.3%, Viking Therapeutics Down 3.3%, Amgen Down 1.4%

THOMSON REUTERS
·
Feb 04

Novo Nordisk Warns on Profits and Sales Amid Trump Drug Price Crackdown

Reuters
·
Feb 04

Structure Therapeutics emerges as top M&A target for big pharma, Axios says

TIPRANKS
·
Jan 30

Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It

Benzinga_recent_news
·
Jan 23

Structure Therapeutics Inc : JP Morgan Raises Target Price to $105 From $65

THOMSON REUTERS
·
Jan 22

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Goldman Sachs

TIPRANKS
·
Jan 20

24H | Springview Rockets Another 16% After a 674% Rally; GPCR Jumps 6% as It Expects Pills to Capture up to 50% of GLP-1 Obesity Market; Hesai Gains 3%

Tiger Newspress
·
Jan 16

Structure Therapeutics CEO Says Compounding Threat Looms For Future Obesity Treatments

Benzinga_recent_news
·
Jan 16

Structure Therapeutics CEO Voices Concerns Over Generic Competition for Weight-Loss Drugs: Challenges Loom Even Before Market Approval

Stock News
·
Jan 15

Structure expects pills to capture up to 50% of GLP-1 obesity market by 2030

Reuters
·
Jan 15

Structure Therapeutics CEO Expects Pills to Capture 25% to 50% of Glp-1 Weight-Loss Market by 2030

THOMSON REUTERS
·
Jan 15

Structure Therapeutics CEO Says Strategic Partner for Commercialization of Its Medicine Needs to Have Strong Relationships With Primary Care Doctors

THOMSON REUTERS
·
Jan 15

What to Watch in the Day Ahead - Wednesday, January 14

Reuters
·
Jan 14

Structure Therapeutics rises 14.1%

TIPRANKS
·
Jan 14

What to Watch in the Day Ahead - Tuesday, January 13

Reuters
·
Jan 13

Funding for Risky Biotechs Is Returning -- WSJ

Dow Jones
·
Jan 13

Structure Therapeutics Inc. unveils oral obesity treatment pipeline in new corporate presentation

Reuters
·
Jan 13

Septerna to Present GPCR Pipeline Updates at JPM Conference

TIPRANKS
·
Jan 12

Press Release: Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

Dow Jones
·
Jan 09

Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%

Tiger Newspress
·
Jan 07